-
2
-
-
0017744944
-
Group sequential methods in the design and analysis of clinical trials
-
Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika. 1977;64:191–199.
-
(1977)
Biometrika
, vol.64
, pp. 191-199
-
-
Pocock, S.J.1
-
3
-
-
0018687930
-
A multiple testing procedure for clinical trials
-
O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549–556.
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O’Brien, P.C.1
Fleming, T.R.2
-
4
-
-
0024401563
-
Group sequential procedures: calendar versus information time
-
Lan KKG, DeMets DL. Group sequential procedures: calendar versus information time. Stat Med. 1987;8:1191–1198.
-
(1987)
Stat Med
, vol.8
, pp. 1191-1198
-
-
Lan, K.K.G.1
DeMets, D.L.2
-
5
-
-
0029589385
-
Designed extension of studies based on conditional power
-
Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics. 1995;51:1315–1324.
-
(1995)
Biometrics
, vol.51
, pp. 1315-1324
-
-
Proschan, M.A.1
Hunsberger, S.A.2
-
6
-
-
0032886394
-
Modification of sample size in group sequential clinical trials
-
Cui L, Hung HM, Wang S. Modification of sample size in group sequential clinical trials. Biometrics. 1999;55:853–857.
-
(1999)
Biometrics
, vol.55
, pp. 853-857
-
-
Cui, L.1
Hung, H.M.2
Wang, S.3
-
7
-
-
0034876356
-
Adaptive group sequential designs for clinical trials: Combining the advantages of adaptive and of classical group sequential approaches
-
Müller H, Schäfer H. Adaptive group sequential designs for clinical trials: Combining the advantages of adaptive and of classical group sequential approaches. Biometrics. 2001;57:886–891.
-
(2001)
Biometrics
, vol.57
, pp. 886-891
-
-
Müller, H.1
Schäfer, H.2
-
8
-
-
1842730273
-
Increasing the sample size when the unblinded interim result is promising
-
Chen YHJ, DeMets DL, Lan KKG. Increasing the sample size when the unblinded interim result is promising. Stat Med. 2004;23:1023–1038.
-
(2004)
Stat Med
, vol.23
, pp. 1023-1038
-
-
Chen, Y.H.J.1
DeMets, D.L.2
Lan, K.K.G.3
-
9
-
-
57349108084
-
Sample size re-estimation for adaptive sequential design in clinical trials
-
Gao P, Ware JH, Mehta C. Sample size re-estimation for adaptive sequential design in clinical trials. J Biopharm Stat. 2008;18:1184–1196.
-
(2008)
J Biopharm Stat
, vol.18
, pp. 1184-1196
-
-
Gao, P.1
Ware, J.H.2
Mehta, C.3
-
11
-
-
84889662412
-
Similarities and differences of Bayesian designs and adaptive designs for medical devices: a regulatory view
-
Campbell G. Similarities and differences of Bayesian designs and adaptive designs for medical devices: a regulatory view. Stat Biopharm Res. 2013;5:356–368.
-
(2013)
Stat Biopharm Res
, vol.5
, pp. 356-368
-
-
Campbell, G.1
-
13
-
-
84907946289
-
Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
-
Elsäßer A, Regnstrom J, Vetter T. Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency. Trials. 2014;15:383.
-
(2014)
Trials
, vol.15
, pp. 383
-
-
Elsäßer, A.1
Regnstrom, J.2
Vetter, T.3
-
15
-
-
0035961473
-
Sample size re-estimation—journey for a decade
-
Shih W. Sample size re-estimation—journey for a decade. Stat Med. 2001;20:515–518.
-
(2001)
Stat Med
, vol.20
, pp. 515-518
-
-
Shih, W.1
-
17
-
-
0004012196
-
-
Boca Raton, FL, CRC Press
-
Gelman A, Carlin J, Stern H, Dunson DB, Vehtari A, Rubin DB. Bayesian Data Analysis. Boca Raton, FL: CRC Press; 2014.
-
(2014)
Bayesian Data Analysis
-
-
Gelman, A.1
Carlin, J.2
Stern, H.3
Dunson, D.B.4
Vehtari, A.5
Rubin, D.B.6
-
18
-
-
37549067785
-
Experience with reviewing Bayesian medical device trials
-
Pennello G, Thompson L. Experience with reviewing Bayesian medical device trials. J Biopharm Stat. 2008;18:81–115.
-
(2008)
J Biopharm Stat
, vol.18
, pp. 81-115
-
-
Pennello, G.1
Thompson, L.2
-
19
-
-
80051730237
-
Bayesian statistics in medical devices: innovation sparked by the FDA
-
Campbell G. Bayesian statistics in medical devices: innovation sparked by the FDA. J Biopharm Stat. 2011;21:871–887.
-
(2011)
J Biopharm Stat
, vol.21
, pp. 871-887
-
-
Campbell, G.1
-
20
-
-
77950189829
-
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
-
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
-
(2010)
BMJ
, vol.340
, pp. c332
-
-
Schulz, K.F.1
Altman, D.G.2
Moher, D.3
-
21
-
-
77950273246
-
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
-
Moher D, Hopewell S, Schulz F. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
-
(2010)
BMJ
, vol.340
, pp. c869
-
-
Moher, D.1
Hopewell, S.2
Schulz, F.3
-
22
-
-
84889644506
-
-
Published 2012. Accessed March 15, 2012
-
Detry M, Lewis L, Broglio K. Standards for the design, conduct, and evaluation of adaptive randomized clinical trials, http://www.pcori.org/assets/Standards-for-the-Design-Conduct-and-Evaluation-of-Adaptive-Randomized-Clinical-Trials.pdf. Published 2012. Accessed March 15, 2012.
-
Standards for the design, conduct, and evaluation of adaptive randomized clinical trials
-
-
Detry, M.1
Lewis, L.2
Broglio, K.3
|